| Not Yet Recruiting | Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies Solid Tumor, Adult, Cytotoxicity | N/A | 2026-12-25 |
| Not Yet Recruiting | BAriaTric Surgery After Breast Cancer Treatment (BATS) Early-stage Breast Cancer, Obesity | N/A | 2026-06-01 |
| Not Yet Recruiting | Rural Smoking Cessation Smoking Cessation | N/A | 2026-05-01 |
| Recruiting | MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan a AML, MDS, Acute Leukemia | Phase 2 | 2026-04-10 |
| Recruiting | LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons Wit Caregiver Burden, Colorectal Cancer, Legal Intervention | N/A | 2025-09-09 |
| Recruiting | HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL Follicular Lymphoma, Marginal Zone Lymphoma | Phase 2 | 2025-08-07 |
| Recruiting | UNTOLD Ovarian Cancer Unmet Needs Survey Ovarian Cancer | — | 2025-07-10 |
| Recruiting | Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagn Acute Myeloid Leukemia, TP53 | Phase 1 / Phase 2 | 2025-07-07 |
| Recruiting | American Indian Smokefree Native RCT Smoking Cessation | N/A | 2025-04-14 |
| Recruiting | Trial of Cell Based Therapy for DMD Duchenne Muscular Dystrophy | Phase 1 | 2025-03-20 |
| Recruiting | Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise Chronic Lung Disease, Chronic Obstructive Pulmonary Disease, Acute Lymphoblastic Leukemia | — | 2025-03-14 |
| Recruiting | Adenovirus (RGDCRAdCOX2F) Adenocarcinoma of Pancreas | Phase 1 | 2024-12-27 |
| Recruiting | MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma Autologous Stem Cell Transplant, Classic Hodgkin Lymphoma | Phase 2 | 2024-12-04 |
| Recruiting | Allo HSCT for High Risk Hemoglobinopathies Graft Failure, Sickle Cell Disease, Hemoglobinopathies | Phase 2 | 2024-11-19 |
| Recruiting | HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML Myeloid Malignancy, Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1 | 2024-11-19 |
| Recruiting | Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures Tobacco Use, Cigarette Smoking, Nicotine Dependence | N/A | 2024-10-12 |
| Terminated | Remote Trial - Tobacco Product Standard (VLNC) Tobacco Use | N/A | 2024-09-11 |
| Withdrawn | Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL Lymphoma Leukemia | Phase 1 / Phase 2 | 2024-09-01 |
| Withdrawn | Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency | Phase 1 | 2024-07-15 |
| Active Not Recruiting | Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Gynecologic Cancer, Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | 2024-07-11 |
| Withdrawn | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma Glioblastoma | Phase 2 | 2024-06-28 |
| Suspended | Effect of Kava on Anxiety and Stress in Cancer Survivors Kava, Anxiety, Stress | EARLY_Phase 1 | 2024-06-20 |
| Recruiting | MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophospham Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia | Phase 2 | 2024-06-05 |
| Completed | Feasibility Study - Filter Ventilation Tobacco Use | N/A | 2024-03-18 |
| Recruiting | Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | — | 2024-02-08 |
| Active Not Recruiting | Assessing the Time Demands of Cancer Metastatic Breast Cancer, Ovarian Cancer | — | 2023-11-13 |
| Recruiting | Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following P Duodenal Neoplasm, Pancreatic Neoplasm | Phase 2 | 2023-11-10 |
| Suspended | MT2022-01: MSCs for ALD Cerebral Adrenoleukodystrophy | Phase 1 | 2023-08-28 |
| Active Not Recruiting | Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors Cancer, HPV Associated Cancer | N/A | 2023-07-24 |
| Terminated | Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids Acute-graft-versus-host Disease | Phase 1 / Phase 2 | 2023-06-05 |
| Recruiting | Study of PAT in Patients With Solid Tumor Cancers Metastasis, Solid Tumor | Phase 1 | 2023-05-19 |
| Recruiting | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies Hematologic Malignancy, Acute Leukemia, Remission | Phase 2 | 2023-05-11 |
| Recruiting | Allo HSCT Using RIC and PTCy for Hematological Diseases Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia | Phase 2 | 2023-05-01 |
| Terminated | MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Cancer, Solid Tumor, Ovarian Cancer | Phase 1 | 2023-04-28 |
| Withdrawn | Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) Prostate Cancer | Phase 2 | 2023-02-01 |
| Completed | EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity Oncology, Chemotherapeutic Toxicity, Metastatic Solid Tumor | N/A | 2023-01-09 |
| Completed | QuitGuide for American Indians: Aims 2 & 3 Tobacco Use, Tobacco Use Disorder | N/A | 2022-12-14 |
| Withdrawn | MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT Mucopolysaccharidosis Type IH (MPS IH, Hurler Syndrome), Mucopolysaccharidosis Type IH, MPS IH, Hurler Syndrome | Phase 1 / Phase 2 | 2022-12-01 |
| Recruiting | RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase Adenocarcinoma of Lung, Lung Cancer | Phase 2 | 2022-11-30 |
| Active Not Recruiting | Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in P Hematopoietic Cell Transplantation, Mucopolysaccharidosis Type I | — | 2022-11-17 |
| Completed | App-Assisted Day Reconstruction to Reduce Logistic Toxicity in Cancer Cancer | — | 2022-07-28 |
| Recruiting | Role of Acetaldehyde in the Development of Oral Cancer Alcohol-Related Carcinoma, Fanconi Anemia, Oral Cavity Carcinoma | N/A | 2022-07-08 |
| Active Not Recruiting | NF-1, Nutraceutical Intervention Neurofibromatosis 1 | Phase 1 | 2022-07-06 |
| Active Not Recruiting | Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users Smoking, Cigarette | Phase 1 | 2022-05-11 |
| Withdrawn | Diagnosis and Treatment of Periodontal Disease in Patients With AML AML, Acute Myelogenous Leukemia | N/A | 2022-05-01 |
| Completed | HCW9218 in Select Advanced Solid Tumors Solid Tumor | Phase 1 | 2022-04-01 |
| Completed | PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasm | Phase 1 / Phase 2 | 2022-03-17 |
| Completed | Sugars in Cigarettes Tobacco Use | N/A | 2022-02-24 |
| Withdrawn | Charcoal in Lung Cancer Patients Undergoing TEMLA Lung Cancer | Phase 2 | 2022-01-26 |
| Completed | FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia Acute Myeloid Leukemia, Myeloid Leukemia, Monocytic Leukemia | Phase 1 | 2021-11-03 |
| Active Not Recruiting | Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure Smokeless Tobacco | Phase 1 | 2021-10-19 |
| Suspended | Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL DLBCL, Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma | Phase 1 / Phase 2 | 2021-06-09 |
| Completed | Telehealth-Filter Ventilation ( COMET2P1 ) Tobacco Use | N/A | 2021-05-26 |
| Terminated | Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy Acute Myeloid Leukemia | — | 2021-05-04 |
| Completed | Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices Smoking, Cigarette | EARLY_Phase 1 | 2021-04-20 |
| Completed | FT516 and IL2 With Enoblituzumab for Ovarian Cancer Ovarian Cancer, Fallopian Tube Adenocarcinoma, Primary Peritoneal Cavity Cancer | Phase 1 | 2021-04-02 |
| Completed | Clinical Trial of Two Study Drinks in Detoxification of Environmental Toxicants and Carcinogens Healthy | Phase 2 | 2021-02-18 |
| Withdrawn | Ethnic/Racial Differences in Metabolism and DNA Adduct Formation Lung Cancer | — | 2020-10-01 |
| Completed | FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1 | 2020-09-22 |
| Completed | Metabolism of NNK in Japanese Americans Smoking | — | 2020-09-01 |
| Active Not Recruiting | Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel Lymphoma | EARLY_Phase 1 | 2020-08-06 |
| Completed | Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19) Acute Respiratory Distress Syndrome, ARDS (Moderate or Severe), COVID-19 Pneumonia | Phase 2 | 2020-07-30 |
| Completed | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia COVID-19 | Phase 1 | 2020-05-14 |
| Completed | Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS Acute Myeloid Leukemia, Myeloid and Monocytic Leukemia, Myelodysplastic Syndromes | Phase 2 | 2020-02-17 |
| Recruiting | Observational Study of Exposure to Environmental Toxicants Among Firefighters Healthy | — | 2020-02-01 |
| Completed | A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers Healthy Adult Volunteers | EARLY_Phase 1 | 2020-01-22 |
| Active Not Recruiting | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone Prostate Cancer | Phase 2 | 2019-10-10 |
| Completed | A Study of FMT in Patients With AML Allo HSCT in Recipients Acute Myeloid Leukemia, Allogeneic Hematopoietic Cell Transplantation | Phase 2 | 2019-09-09 |
| Completed | Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer TN ER-/PR-/HER2- Breast Cancer, Triple Negative Breast Cancer, HER2-positive Breast Cancer | — | 2019-08-08 |
| Completed | Radiation and Combination Immunotherapy for Melanoma Metastatic Melanoma | Phase 2 | 2019-05-28 |
| Recruiting | Adrenoleukodystrophy National Registry Study ALD (Adrenoleukodystrophy), Adrenoleukodystrophy, Cerebral Adrenoleukodystrophy | — | 2019-05-01 |
| Active Not Recruiting | Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Biphenotypic/Undifferentiated Leukemia | Phase 2 | 2019-01-02 |
| Active Not Recruiting | MT2017-45: CAR-T Cell Therapy for Heme Malignancies Acute Lymphoblastic Leukemia, Large B-cell Lymphoma | Phase 2 | 2018-12-18 |
| Withdrawn | Study of CD133KDEL Toxin in the Treatment for Solid Tumors Solid Tumors | Phase 1 | 2018-12-01 |
| Completed | Trial of Indole-3-Carbinol and Silibinin Smoking | Phase 1 | 2018-11-29 |
| Completed | CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig Lymphoma, Multiple Myeloma | Phase 1 | 2018-11-16 |
| Recruiting | Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders Fanconi Anemia, Severe Aplastic Anemia, Myelodysplastic Syndromes | Phase 2 | 2018-11-13 |
| Withdrawn | Early Diagnosis Of Childhood Cerebral ALD Adrenoleukodystrophy | — | 2018-11-01 |
| Withdrawn | QUILT-3.034: Non-Myeloablative TCRa/b Deplete Haplo HSCT With Post ALT-803 for AML High-Risk Acute Myeloid Leukemia, Treatment-Related Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia | Phase 2 | 2018-10-30 |
| Completed | COMET2 Project 1 Filter Ventilation Study Smoking, Tobacco Use | Phase 3 | 2018-10-18 |
| Completed | Exemestane in Post-Menopausal Women With NSCLC Non-Small Cell Lung Cancer | Phase 2 | 2018-09-27 |
| Terminated | Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies Immune and Microbial Reconstitution, Systemic Viral Infection, Acute-graft-versus-host Disease | — | 2018-09-21 |
| Completed | Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training Allogeneic HCT Survivors | — | 2018-09-10 |
| Completed | Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS Acute Myeloid Leukemia, Higher Risk Myelodysplastic Syndrome | Phase 2 | 2018-08-13 |
| Terminated | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Condi Sickle Cell Disease, Thalassemia, High Risk Hematologic Disorders | Phase 2 | 2018-07-02 |
| Recruiting | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | 2018-03-30 |
| Withdrawn | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma Metastatic Melanoma, Pulmonary Metastases, Hepatic Metastases | Phase 1 / Phase 2 | 2018-01-31 |
| Completed | BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle I Muscle Invasive Bladder Cancer | Phase 2 | 2018-01-29 |
| Completed | Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Acute Myeloid Leukemia | — | 2018-01-02 |
| Completed | Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) Breast Cancer | N/A | 2017-12-27 |
| Completed | Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 1 | 2017-10-19 |
| Completed | Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma | Phase 1 | 2017-10-18 |
| Completed | IP ALT-803 Followed by SQ ALT-803 for Ovarian Cancer FIGO Stage III and IV Ovarian Cancer, FIGO Stage III and IV Fallopian Tube Cancer, FIGO Stage III Primary Peritoneal Cancer | Phase 2 | 2017-09-19 |
| Completed | Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction Chemotherapy-Induced Gut Barrier Damage, Acute Leukemia | — | 2017-08-22 |
| Completed | QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML Acute Myeloid Leukemia | Phase 2 | 2017-05-16 |
| Completed | UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia/Lymphoma | Phase 2 | 2017-05-15 |
| Completed | Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML Refractory Acute Myelogenous Leukemia, Relapsed Acute Myelogenous Leukemia | Phase 1 | 2017-04-27 |
| Recruiting | Auto Stem Cell Transplant for Lymphoma Patients Non-Hodgkin Lymphoma, Hodgkin Lymphoma | Phase 2 | 2017-04-20 |
| Completed | Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) | Phase 2 | 2017-04-12 |
| Withdrawn | StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia | Phase 2 | 2017-04-01 |
| Terminated | Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors Germ Cell Tumor | Phase 2 | 2017-03-29 |
| Completed | Allo HSCT Using RIC for Hematological Diseases Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia | Phase 2 | 2017-03-09 |
| Terminated | Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Natural Killer Cell Malignancies | Phase 2 | 2017-02-16 |
| Completed | Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT Hematologic Malignancies | Phase 2 | 2017-01-24 |
| Recruiting | Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia | N/A | 2016-12-01 |
| Completed | Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism Smoking | Phase 1 | 2016-12-01 |
| Completed | Study of Cellutome System for Treatment of Individual Lesions in EB Pts Epidermolysis Bullosa | N/A | 2016-08-04 |
| Withdrawn | Treg Cells for AGVHD in Non-myeloablative UCB Transplant Hematologic Malignancies | Phase 2 | 2016-06-01 |
| Recruiting | Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neurobla Neuroblastoma | Phase 2 | 2016-06-01 |
| Completed | MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs Epidermolysis Bullosa | Phase 2 | 2016-03-01 |
| Completed | Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD Graft vs Host Disease | Phase 1 / Phase 2 | 2016-03-01 |
| Terminated | Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome Maroteaux-Lamy Syndrome | N/A | 2016-01-26 |
| Completed | HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma Refractory B-Lineage Leukemia, Relapsed B-Lineage Leukemia, Refractory B-Lineage Lymphoma | Phase 1 / Phase 2 | 2015-12-21 |
| Completed | Investigation of Kava Effects on NNK Metabolism Tobacco Smoking | N/A | 2015-12-03 |
| Completed | MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients Acute Myelogenous Leukemia | Phase 2 | 2015-10-01 |
| Withdrawn | MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) Cerebral Adrenoleukodystrophy | Phase 1 | 2015-06-01 |
| Completed | Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients Postoperative Complications, Obesity, Gynecologic Neoplasms | N/A | 2015-05-01 |
| Completed | Safety of Romiplostim (Nplate®) Following UCBT Hematologic Malignancies | Phase 1 | 2015-04-10 |
| Completed | Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation Osteopenia, Osteoporosis | Phase 2 | 2015-02-01 |
| Completed | MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients Fungal Infection | Phase 1 | 2015-01-19 |
| Completed | Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia Dyskeratosis Congenita, Aplastic Anemia | N/A | 2015-01-10 |
| Recruiting | Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation Primary Graft Failure, Secondary Graft Failure | — | 2014-10-06 |
| Terminated | Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases Acute Leukemias, Burkitt's Lymphoma, Chronic Myelogenous Leukemia | N/A | 2014-10-01 |
| Terminated | Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies Sickle Cell Disease, Transfusion Dependent Alpha- or Beta- Thalassemia, Diamond Blackfan Anemia | N/A | 2014-09-02 |
| Completed | Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Periton Ovarian Cancer, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Phase 1 | 2014-07-28 |
| Active Not Recruiting | MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis Mucopolysaccharidosis Disorders, Hurler Syndrome, Hunter Syndrome | Phase 2 | 2014-07-10 |
| Completed | ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL Diffuse Large B Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2014-05-01 |
| Withdrawn | T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies Hematologic Malignancy, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia | Phase 1 / Phase 2 | 2014-01-01 |
| Terminated | Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies Hematologic Malignancy | N/A | 2014-01-01 |
| Completed | DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma Leukemia, Lymphoma | Phase 1 | 2013-12-02 |
| Completed | MIBG for Refractory Neuroblastoma and Pheochromocytoma Relapsed Neuroblastoma, Metastatic Pheochromocytoma | N/A | 2013-12-01 |
| Completed | Tobacco Constituents and Biomarkers Smoking | — | 2013-12-01 |
| Withdrawn | Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | 2013-12-01 |
| Terminated | AHN-12 Biodistribution in Advanced Leukemia Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia | Phase 1 | 2013-12-01 |
| Completed | IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndromes (MDS) | Phase 1 / Phase 2 | 2013-11-11 |
| Completed | Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplant Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia | Phase 1 | 2013-11-08 |
| Withdrawn | CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in Fi Acute Myelogenous Leukemia | Phase 2 | 2013-10-01 |
| Terminated | Vegetable Intake Effect on Heterocyclic Amine Metabolism Colon Cancer | N/A | 2013-09-19 |
| Completed | Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Myelodysplastic Syndrome | Phase 2 | 2013-03-01 |
| Terminated | Busulfan and Cyclophosphamide Followed By ALLO BMT Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome | N/A | 2013-01-01 |
| Completed | Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study Cervical Cancer, Uterine Endometrial Cancer, Ovarian Cancer | EARLY_Phase 1 | 2013-01-01 |
| Completed | Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer Metastatic Prostate Cancer | Phase 2 | 2012-10-01 |
| Active Not Recruiting | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies SCID, Omenn's Syndrome, Reticular Dysgenesis | N/A | 2012-09-04 |
| Completed | Total Marrow Irradiation for Refractory Acute Leukemia Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma | Phase 1 | 2012-08-01 |
| Recruiting | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) Hematologic Disorders, Hemoglobinopathies, Immunodeficiencies | N/A | 2012-08-01 |
| Terminated | Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma Diffuse Intrinsic Pontine Glioma | Phase 1 | 2012-07-17 |
| Completed | Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders Lysosomal Storage Disease, Peroxisomal Disorder | N/A | 2012-07-11 |
| Completed | Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy Breast Cancer, Colorectal Cancer, Ovarian Cancer | N/A | 2012-07-01 |
| Completed | Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma | Phase 2 | 2012-06-01 |
| Completed | Administration of IV Laronidase Post Bone Marrow Transplant in Hurler Hurler Syndrome | Phase 1 | 2012-05-29 |
| Completed | Biomarker Feedback for Smoking Cessation Cigarette Smoking | N/A | 2012-05-01 |
| Completed | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma Neuroblastoma | N/A | 2012-03-28 |
| Terminated | Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndr Mucopolysaccharidosis Type IH, MPS I, Hurler Syndrome | — | 2012-03-28 |
| Recruiting | Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units Lymphatic Diseases, Hematopoietic Malignancy | N/A | 2011-10-20 |
| Completed | Auto Transplant for High Risk or Relapsed Solid or CNS Tumors Ewing's Family Tumors, Renal Tumors, Hepatoblastoma | N/A | 2011-10-20 |
| Terminated | T-Cell Depleted Double UCB for Refractory AML Acute Myelogenous Leukemia, Refractory Acute Myelogenous Leukemia | Phase 2 | 2011-10-01 |
| Completed | NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | 2011-09-01 |
| Completed | Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) Acute Myelogenous Leukemia, Myelodysplastic Syndrome | Phase 1 | 2011-09-01 |
| Terminated | Preservation of Ovarian Function After Hematopoietic Cell Transplant Multiple Myeloma, Non-Hodgkin Lymphoma, Hodgkin Disease | Phase 2 | 2011-07-01 |
| Completed | Selecting a Favorable KIR Donor in Unrelated HCT for AML Acute Myelogenous Leukemia | N/A | 2011-06-01 |
| Terminated | Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Acute Lymphoblastic Leukemia | Phase 2 | 2011-06-01 |
| Completed | Metabolism of NNK Among African Americans Lung Cancer | — | 2010-12-01 |
| Terminated | Influenza Vaccine Post Allogeneic Transplant Hematopoietic Stem Cell Transplant, Hematologic Malignancy | N/A | 2010-09-01 |
| Completed | Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor Brain Tumor, Glioblastoma, Medulloblastoma | Phase 1 | 2010-09-01 |
| Terminated | Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy Pancreatic Cancer | Phase 2 | 2010-09-01 |
| Completed | Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia | Phase 2 | 2010-08-01 |
| Terminated | WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma | N/A | 2010-07-27 |
| Terminated | Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) Leukemia, Myelogenous, Acute | Phase 2 | 2010-07-01 |
| Completed | Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 2 | 2010-07-01 |
| Completed | Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer Breast Cancer | Phase 1 | 2010-05-26 |
| Completed | IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread Cancer of the Liver, Liver Cancer, Hepatoma | Phase 1 | 2010-04-01 |
| Terminated | Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiatio Leukemia, Lymphoma, Multiple Myeloma | Phase 1 / Phase 2 | 2010-03-01 |
| Completed | Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs Epidermolysis Bullosa | Phase 1 / Phase 2 | 2010-01-01 |
| Completed | Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders Mucopolysaccharidosis, Hurler Syndrome, Hunter Syndrome | Phase 2 | 2009-12-01 |
| Terminated | Study of Pazopanib and Ixabepilone in Patients With Solid Tumors Breast Cancer, Lung Cancer, Colon Cancer | Phase 1 | 2009-12-01 |
| Terminated | Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Can Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 1 / Phase 2 | 2009-04-01 |
| Terminated | Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia Leukemia, Lymphoma | Phase 2 | 2009-04-01 |
| Completed | Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer Breast Cancer | N/A | 2009-04-01 |
| Terminated | Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders Lymphoproliferative Disorder | Phase 2 | 2009-03-01 |
| Terminated | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukem Leukemia, Myelodysplastic Syndrome | Phase 2 | 2009-01-01 |
| Terminated | Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in T Leukemia | Phase 2 | 2009-01-01 |
| Completed | Iron Overload in Patients Undergoing Donor Stem Cell Transplant Cancer, Hematopoietic Stem Cell Transplantation, Allogeneic Hematopoietic Cell Transplantation | — | 2008-12-01 |
| Withdrawn | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases Breast Cancer, Kidney Cancer, Lung Cancer | Phase 1 / Phase 2 | 2008-09-01 |
| Terminated | Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca Breast Cancer | Phase 2 | 2008-09-01 |
| Withdrawn | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patient Lung Cancer | Phase 2 | 2008-08-01 |
| Completed | Allogeneic Transplantation For Severe Osteopetrosis Severe Osteopetrosis | Phase 2 / Phase 3 | 2008-08-01 |
| Withdrawn | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery Breast Cancer | Phase 2 | 2008-07-01 |
| Terminated | Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Ce Graft Versus Host Disease, Leukemia, Lymphoma | Phase 1 | 2008-06-01 |
| Completed | Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma Stage IV Melanoma | Phase 2 | 2008-06-01 |
| Completed | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors Breast Cancer, Colorectal Cancer, Head and Neck Cancer | Phase 1 | 2008-05-01 |
| Terminated | Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Periton Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 2008-03-01 |
| Terminated | Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism Hurler's Syndrome, Maroteaux-Lamy Syndrome, Sly Syndrome | Phase 2 | 2008-03-01 |
| Completed | Intrathecal Enzyme Replacement for Hurler Syndrome Hurler Syndrome | Phase 1 | 2008-01-02 |
| Terminated | Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transp Cancer | Phase 2 | 2008-01-01 |
| Terminated | Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leu Leukemia | Phase 1 | 2008-01-01 |
| Terminated | Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapse Leukemia, Lymphoma | Phase 1 / Phase 2 | 2008-01-01 |
| Completed | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies Peritoneal Cavity Cancer | Phase 1 | 2007-10-01 |
| Terminated | Reduced Intensity AlloTransplant For Osteopetrosis Osteopetrosis | Phase 2 | 2007-09-01 |
| Terminated | Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant Breast Cancer, Iron Overload, Leukemia | Phase 2 | 2007-08-01 |
| Completed | Empowering Cancer Survivors Through Information Technology Cancer Survivor | N/A | 2007-08-01 |
| Completed | Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA Dyskeratosis Congenita, Aplastic Anemia | Phase 2 / Phase 3 | 2007-08-01 |
| Completed | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer Leukemia, Lymphoma, Multiple Myeloma | Phase 1 | 2007-07-23 |
| Completed | Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer Ovarian Cancer | Phase 2 | 2007-06-01 |
| Terminated | Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Graft Versus Host Disease, Leukemia, Lymphoma | Phase 1 | 2007-05-01 |
| Terminated | Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa Epidermolysis Bullosa | N/A | 2007-04-01 |
| Completed | Clinical Trial of Trametes Versicolor in Women With Breast Cancer Breast Cancer | Phase 1 | 2007-04-01 |
| Completed | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | Phase 2 | 2007-03-01 |
| Completed | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors Breast Cancer, Colorectal Cancer, Head and Neck Cancer | Phase 1 | 2007-03-01 |
| Terminated | Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis Histiocytosis, Langerhans-cell | Phase 2 | 2007-01-01 |
| Withdrawn | Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer Cervical Cancer | Phase 1 | 2007-01-01 |
| Completed | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer | Phase 2 | 2007-01-01 |
| Completed | Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors Childhood Germ Cell Tumor, Ovarian Cancer, Teratoma | Phase 2 | 2006-12-19 |
| Completed | Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Lung Cancer | Phase 2 | 2006-09-01 |
| Completed | HSCT for High Risk Inherited Inborn Errors Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy | Phase 2 | 2006-09-01 |
| Terminated | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia Leukemia | Phase 2 / Phase 3 | 2006-07-26 |
| Terminated | Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer Breast Cancer | Phase 2 | 2006-07-01 |
| Completed | CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervic Cervical Cancer, Endometrial Cancer, Ovarian Cancer | Phase 2 | 2006-07-01 |
| Completed | TBI Dose De-escalation for Fanconi Anemia Fanconi Anemia | Phase 2 / Phase 3 | 2006-05-18 |
| Completed | PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma Sarcoma | N/A | 2006-04-10 |
| Completed | Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers Breast Cancer, Ovarian Cancer, Endometrial Cancer | Phase 2 | 2006-04-01 |
| Terminated | Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent Lung Cancer | Phase 1 | 2006-04-01 |
| Terminated | Allogeneic Natural Killer (NK) Cells in Patients With Advanced Metastatic Breast Cancer Breast Cancer | Phase 2 | 2006-04-01 |
| Terminated | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2006-03-01 |
| Terminated | Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients W Leukemia, Myelodysplastic Syndromes | Phase 2 | 2006-02-01 |
| Terminated | Study of Immune Response Modifier in the Treatment of Hematologic Malignancies Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma | Phase 2 | 2006-01-01 |
| Completed | Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors Breast Cancer, Colorectal Cancer, Head and Neck Cancer | Phase 1 | 2005-11-01 |
| Completed | Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia Leukemia, Myelodysplastic Syndromes, Childhood Acute Myeloid Leukemia in Remission | Phase 2 | 2005-11-01 |
| Terminated | Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 2 | 2005-10-01 |
| Completed | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymph Lymphoma | Phase 2 | 2005-08-24 |
| Terminated | MT2004-30: Tomotherapy for Solid Tumors Brain and Central Nervous System Tumors, Kidney Cancer, Liver Cancer | Phase 1 | 2005-08-01 |
| Completed | Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia | Phase 2 | 2005-07-28 |
| Terminated | Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia Leukemia, Myelodysplastic Syndromes | Phase 1 | 2005-07-01 |
| Completed | Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Endometrial Cancer | Phase 2 | 2005-07-01 |
| Terminated | Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other Disease Leukemia, Myelodysplastic Syndromes | Phase 2 | 2005-07-01 |
| Completed | Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant Myeloproliferative Disorders, Leukemia, Lymphoma | Phase 2 | 2005-06-01 |
| Terminated | Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Myeloproliferative Disorders, Leukemia, Lymphoma | Phase 1 / Phase 2 | 2005-06-01 |
| Completed | Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine Ovarian Cancer, Peritoneal Primary Cancer, Fallopian Tube Cancer | N/A | 2005-05-01 |
| Withdrawn | MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer Breast Cancer | Phase 2 | 2005-03-01 |
| Completed | Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia Leukemia | Phase 2 | 2005-03-01 |
| Completed | Topotecan, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Cervical Cancer Cervical Cancer | Phase 1 | 2005-02-01 |
| Terminated | Chemoradiation in Locally Advanced Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2005-01-01 |
| Completed | Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Tra Acute Myelogenous Leukemia | Phase 1 / Phase 2 | 2005-01-01 |
| Terminated | Mitomycin as a Hyperthermic Peritoneal Perfusion in Treating Patients With Malignant Ascites Metastatic Cancer | Phase 2 | 2004-08-01 |
| Terminated | Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer | Phase 1 | 2004-08-01 |
| Completed | Autologous Transplant for Multiple Myeloma Multiple Myeloma | Phase 2 / Phase 3 | 2004-04-20 |
| Completed | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer | Phase 1 | 2004-03-01 |
| Terminated | Stem Cell Transplantation for Fanconi Anemia Fanconi Anemia | Phase 1 / Phase 2 | 2004-03-01 |
| Completed | Stem Cell Transplant w/Laronidase for Hurler Mucopolysaccharidosis I, Hurler Syndrome | Phase 2 | 2004-03-01 |
| Terminated | Post Transplant Donor Lymphocyte Infusion Leukemia, Myeloid, Chronic, Lymphomas, Multiple Myeloma | Phase 2 | 2004-01-01 |
| Completed | Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors Neoplasms | Phase 1 | 2003-10-01 |
| Terminated | CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant Germ Cell Tumor, Leukemia, Lymphoma | Phase 1 | 2003-09-01 |
| Terminated | Bronchial Artery Infusion of Gemcitabine in Treating Patients With Recurrent or Progressive Non-Small Cell Lun Lung Cancer | Phase 1 | 2003-01-01 |
| Terminated | Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ Breast Cancer | Phase 2 | 2002-12-01 |
| Completed | Stem Cell Transplant for Immunologic or Histiocytic Disorders Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome | Phase 2 | 2002-08-01 |
| Terminated | Vaccination With Tetanus and KLH to Assess Immune Responses. Cancer | — | 2002-07-01 |
| Completed | Stem Cell Transplant for Hemoglobinopathy Sickle Cell Disease, Thalassemia, Severe Congenital Neutropenia | Phase 2 / Phase 3 | 2002-06-01 |
| Terminated | Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lu Lung Cancer | Phase 2 | 2002-05-01 |
| Completed | Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia Fanconi Anemia | Phase 2 | 2002-03-26 |
| Terminated | Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy Kidney Cancer, Leukemia, Lymphoma | Phase 2 | 2002-03-26 |
| Terminated | Stem Cell Transplant for Hematological Malignancy Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute | N/A | 2001-10-01 |
| Completed | Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and M Chronic Myeloproliferative Disorders, Leukemia, Lymphoma | N/A | 2001-04-01 |
| Terminated | T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders Hemophagocytic Lymphohistiocytosis, X-Linked Lymphoproliferative Disorders, Chediak-Higashi Syndrome | Phase 2 / Phase 3 | 2000-09-01 |
| Terminated | Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemi Leukemia | Phase 2 | 2000-08-01 |
| Terminated | Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leuk Leukemia | Phase 2 | 2000-08-01 |
| Completed | Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Ly Lymphoma | Phase 2 | 2000-08-01 |
| Terminated | Filgrastim Compared With Sargramostim Plus Chemotherapy, Peripheral Stem Cell Transplantation, and Interferon Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2000-08-01 |
| Terminated | Stem Cell Transplantation for Hematological Malignancies Leukemia, Lymphocytic, Acute, AML, MDS | Phase 2 / Phase 3 | 2000-06-07 |
| Completed | Stem Cell Transplant for Bone Marrow Failure Syndromes Diamond-Blackfan Anemia, Kostmann's Neutropenia, Shwachman-Diamond Syndrome | Phase 2 / Phase 3 | 2000-06-01 |
| Completed | Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating P Breast Cancer, Kidney Cancer, Leukemia | Phase 1 / Phase 2 | 2000-06-01 |
| Completed | Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Fanconi Anemia | Phase 1 / Phase 2 | 2000-02-17 |
| Withdrawn | Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma | Phase 2 | 2000-01-01 |
| Completed | Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) Juvenile Myelomonocytic Leukemia | Phase 1 / Phase 2 | 1999-11-18 |
| Completed | Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 1999-10-06 |
| Terminated | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Chronic Myeloproliferative Disorders, Diamond-blackfan Anemia, Fanconi Anemia | N/A | 1999-10-01 |
| Terminated | Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Leukemia | Phase 1 / Phase 2 | 1999-06-01 |
| Terminated | Biological Therapies Following Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Ly Breast Cancer, Lymphoma | Phase 1 | 1999-05-01 |
| Completed | Stem Cell Transplantation for Hurler Mucopolysaccharidosis I, Mucopolysaccharidosis VI, Mannosidosis | Phase 2 | 1999-05-01 |
| Terminated | Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Chordoma | Phase 1 | 1998-11-01 |
| Withdrawn | Bone Marrow Transplantation in Treating Patients With Leukemia Graft Versus Host Disease, Leukemia, Lymphoma | Phase 3 | 1996-04-01 |
| Completed | Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) Leukemia Leukemia, Myeloid, Chronic, AML, MDS | N/A | 1995-12-01 |
| Completed | Stem Cell Transplant for Inborn Errors of Metabolism Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy | Phase 2 / Phase 3 | 1995-01-01 |
| No Longer Available | Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma Multiple Myeloma | — | — |